RAMM Pharma Corp.
RAMM
CNSX
| 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -47.68% | -51.73% | -80.26% | -112.07% | 57.09% |
| Total Depreciation and Amortization | -24.50% | -14.85% | -15.24% | -10.55% | -20.58% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 169.57% | 171.04% | 196.63% | 306.03% | -78.11% |
| Change in Net Operating Assets | 2,811.64% | 292.14% | 617.70% | 504.38% | -137.31% |
| Cash from Operations | 67.24% | 42.10% | 31.39% | 8.45% | 7.58% |
| Capital Expenditure | 72.13% | 48.03% | 15.08% | 24.18% | -635.90% |
| Sale of Property, Plant, and Equipment | 475.83% | 440.19% | -- | -- | 173.94% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -118.45% | -118.96% | -175.05% | -98.91% | -76.12% |
| Cash from Investing | 685.85% | 370.37% | -200.24% | -136.67% | 110.49% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 19.20% | -0.55% | -3.88% | 9.53% | 11.16% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 92.94% | 252.17% | -100.00% | -100.00% | 126.23% |
| Cash from Financing | 24.65% | 37.30% | 30.88% | 44.53% | 50.34% |
| Foreign Exchange rate Adjustments | -138.12% | -137.50% | 3,616.67% | -95.33% | 0.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 79.97% | 55.35% | 27.87% | 8.27% | 25.82% |